RecruitingNCT06664112

Delivery Outcomes by AIDA (Artificial Intelligence Dystocia Algorithm) Analysis

Study of Delivery Outcomes After AIDA (Artificial Intelligence Dystocia Algorithm) Analysis


Sponsor

Centro di Ricerca Clinica Salentino

Enrollment

1,000 participants

Start Date

Sep 30, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Aims: Primary aim is to investigate outcomes of eutocic labor, evaluating intrapartum ultrasound parameters by AIDA method: Angle of progression (AoP), Asynclitism degree (AD), fetal head-symphysis distance (HSD), and midline angle (MLA). Secondary aim is to investigate outcomes of dystocic labor, evaluating intrapartum ultrasound parameters by AIDA method: Angle of progression (AoP), Asynclitism degree (AD), fetal head-symphysis distance (HSD), and midline angle (MLA). Tertiary aim is to investigate of neonatal outcomes of eutocic labor: Apgar scores at 1 min, Apgar scores at 5 min. Quaternary aim is to investigate of neonatal outcomes of dystocic labor: Apgar scores at 1 min, Apgar scores at 5 min.


Eligibility

Sex: FEMALEMin Age: 20 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called AIDA Analysis for people with delivery complication, delivery problem, and other related conditions. The study is currently recruiting participants at 2 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAIDA Analysis

The women will be followed until and after the birth, under intrapartum ultrasound monitoring, with all clinical, ultrasonographic and obstetric parameters, analyzed by AIDA method.


Locations(2)

Ospedale Veris delli Ponti

Scorrano, Lecce, Italy

Andrea Tinelli

Lecce, Le, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06664112


Related Trials